Seelos Therapeutics announces 1-for-16 reverse stock split
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 25 2024
0mins
Reverse Stock Split Announcement: Seelos Therapeutics' Board of Directors approved a 1-for-16 reverse stock split effective September 27, 2024, to comply with Nasdaq's minimum bid price requirement of $1.00 per share.
Trading Details: After the split, the company's common stock will continue trading on the Nasdaq under the symbol "SEEL" with a new CUSIP number, 81577F 406.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
